Advertisement
Home »

Tolebrutinib Slows Disability Worsening in Relapsing MS

Nov 11, 2024

REFERENCES & ADDITIONAL READING

  1. Oh J, et al. Efficacy and safety of tolebrutinib versus teriflunomide in relapsing multiple sclerosis: Results from the phase 3 GEMINI 1 and 2 trials. Abstract O135, ECTRIMS 2024, 17–20 October 2024, Copenhagen, Denmark.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement